Nicole Mowad-Nassar
Nicole Mowad-Nassar is Senior Vice President, AbbVie and President, Global Allergan Aesthetics. In the Botulinum Index graph, she represents the current commercial leadership node for AbbVie’s aesthetic portfolio, including the business context around Botox Cosmetic.
Her role matters because Allergan Aesthetics is not simply a legacy Allergan name inside AbbVie. It operates as the dedicated aesthetics business that carries Botox Cosmetic, Juvederm, CoolSculpting, and related aesthetic products under the AbbVie umbrella.
Role Context
Section titled “Role Context”| Field | Detail |
|---|---|
| Current organization | AbbVie / Allergan Aesthetics |
| Current role | Senior Vice President, AbbVie and President, Global Allergan Aesthetics |
| Relevant company node | AbbVie / Allergan |
| Relevant brand node | Botox |
| Social profile |
Career Notes
Section titled “Career Notes”- Mowad-Nassar leads AbbVie’s global aesthetics portfolio, a business that includes science-based products and technologies in aesthetic medicine.
- Before taking the Global Allergan Aesthetics role, she served as President of Specialty and U.S. Therapeutics Operations.
- She joined AbbVie in 2018 as Vice President, Commercial Analytics and Operations.
- During AbbVie’s Allergan acquisition work, she led commercial diligence and later served as Global Commercial Integration Lead.
- Her earlier career included commercial leadership roles at Takeda and Abbott.
Activity and Public Context
Section titled “Activity and Public Context”Mowad-Nassar was introduced to aesthetics-industry audiences as the newly appointed President of Global Allergan Aesthetics at the Women in Aesthetics Leadership Conference in 2025. That public transition helps mark the handoff from the initial post-acquisition Allergan Aesthetics leadership period to the current AbbVie aesthetics leadership structure.